National Institute on Drug Abuse; Amended Notice of Meeting, 50595 [2024-13068]

Download as PDF Federal Register / Vol. 89, No. 116 / Friday, June 14, 2024 / Notices Date: July 11, 2024. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Joshua D. Powell, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–5370, josh.powell@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in Gastroenterology. Date: July 11, 2024. Time: 10:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Frederique Yiannikouris, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–3313, frederique.yiannikouris@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in Endocrinology and Metabolism. Date: July 11, 2024. Time: 12:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Hui Chen, M.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6164, Bethesda, MD 20892, 301– 435–1044, chenhui@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: June 10, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–13085 Filed 6–13–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES ddrumheller on DSK120RN23PROD with NOTICES1 National Institutes of Health National Institute on Drug Abuse; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Institute on Drug Abuse Special Emphasis Panel, Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment, June 27, 2024, 01:00 p.m. to June 27, 2024, 05:00 p.m., VerDate Sep<11>2014 17:13 Jun 13, 2024 Jkt 262001 National Institute of Health, National Institute on Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD, 20892 which was published in the Federal Register on April 12, 2024, FR Doc 2024–07797, 89 FR 25886. This notice is being amended to change the meeting contact person from Brian Stefan Wolff, Ph.D., to Ipolia Ramadan, Ph.D., National Institute on Drug Abuse, National Institutes of Health, 301 North Stonestreet Avenue, Bethesda, MD 20892, ramadanir@ mail.nih.gov, (301) 827–4471. The meeting location, date, and time remain the same. The meeting is closed to the public. Dated: June 10, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–13068 Filed 6–13–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection Notice of Issuance of Final Determination Concerning UPanelS LED Display Panels U.S. Customs and Border Protection, Department of Homeland Security. ACTION: Notice of final determination. AGENCY: This document provides notice that U.S. Customs and Border Protection (CBP) has issued a final determination concerning the country of origin of various models of LED display panels sold under the UPanelS brand. Based upon the facts presented, CBP has concluded in the final determination that the components of the subject UPanelS devices undergo substantial transformation in Taiwan upon the manufacture of their printed circuit board assembly (PCBA) and lightemitting diode (LED) lamp assembly. DATES: The final determination was issued on June 10, 2024. A copy of the final determination is attached. Any party-at-interest, as defined in 19 CFR 177.22(d), may seek judicial review of this final determination within July 15, 2024. FOR FURTHER INFORMATION CONTACT: Austen Walsh, Valuation and Special Programs Branch, Regulations and Rulings, Office of Trade, at austen.m.walsh@cbp.dhs.gov. SUPPLEMENTARY INFORMATION: Notice is hereby given that on June 10, 2024, CBP issued a final determination concerning SUMMARY: PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 50595 the country of origin of various models of LED display panels sold under the UPanelS brand for purposes of title III of the Trade Agreements Act of 1979. This final determination, HQ H332752, was issued at the request Unilumin USA LLC (Unilumin), under procedures set forth at 19 CFR part 177, subpart B, which implements Title III of the Trade Agreements Act of 1979, as amended (19 U.S.C. 2511–18). In the final determination, CBP has concluded that, based upon the facts presented, the components, which are largely sourced from China and Taiwan, are substantially transformed in Taiwan when made into the subject UPanelS devices. Section 177.29, CBP Regulations (19 CFR 177.29), provides that notice of final determinations shall be published in the Federal Register within 60 days of the date the final determination is issued. Section 177.30, CBP Regulations (19 CFR 177.30), provides that any party-at-interest, as defined in 19 CFR 177.22(d), may seek judicial review of a final determination within 30 days of publication of such determination in the Federal Register. Alice A. Kipel, Executive Director, Regulations and Rulings, Office of Trade. HQ H332752 June 10, 2024 OT:RR:CTF:VS H332752 AMW CATEGORY: Origin Ms. Angelica Tsakiridis Managing Director—Global Trade Advisory Deloitte LLP 555 Mission Street, Suite 1400 San Francisco, CA 94105 RE: U.S. Government Procurement; Title III, Trade Agreements Act of 1979 (19 U.S.C. 2511); Subpart B, Part 177, CBP Regulations; Country of Origin of UPanelS Products Dear Ms. Tsakiridis: This is in response to your request, dated September 8, 2021, on behalf of your client, Unilumin USA LLC (‘‘Unilumin’’), for a final determination concerning the country of origin of the ‘‘UPanelS’’ product line of lightemitting diode (‘‘LED’’) display panels, pursuant to Title III of the Trade Agreements Act of 1979 (‘‘TAA’’), as amended (19 U.S.C. 2511 et seq.), and subpart B of Part 177, U.S. Customs and Border Protection (‘‘CBP’’) Regulations (19 CFR 177.21, et seq.). Your request, submitted as an electronic ruling request, was forwarded to this office from the National Commodity Specialist Division. Unilumin is a party-at-interest within the meaning of 19 CFR 177.22(d)(1) and 177.23(a) and is therefore entitled to request this final determination. E:\FR\FM\14JNN1.SGM 14JNN1

Agencies

[Federal Register Volume 89, Number 116 (Friday, June 14, 2024)]
[Notices]
[Page 50595]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-13068]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Institute on Drug Abuse Special Emphasis Panel, Mechanistic Research on 
Neuromodulation for Substance Use Disorders Treatment, June 27, 2024, 
01:00 p.m. to June 27, 2024, 05:00 p.m., National Institute of Health, 
National Institute on Drug Abuse, 301 North Stonestreet Avenue, 
Bethesda, MD, 20892 which was published in the Federal Register on 
April 12, 2024, FR Doc 2024-07797, 89 FR 25886.
    This notice is being amended to change the meeting contact person 
from Brian Stefan Wolff, Ph.D., to Ipolia Ramadan, Ph.D., National 
Institute on Drug Abuse, National Institutes of Health, 301 North 
Stonestreet Avenue, Bethesda, MD 20892, [email protected], (301) 
827-4471.
    The meeting location, date, and time remain the same. The meeting 
is closed to the public.

    Dated: June 10, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-13068 Filed 6-13-24; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.